Drawing for DR. WELVIE

USPTO serial 77507757

DR. WELVIE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BRECKENFELD, WILLIAM G
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DR. WELVIE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephanie K. Wade

Stephanie K. Wade Dickstein Shapiro LLP1825 Eye St., NWWashington, DC 20006UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009computer software to assist consumers in making informed health care decisionsACTIVE—
035Business consulting services to manage utilization, costs, risks and quality of health care treatments; providing financial health care reports to the order and/or specification of others; compiling data for business management, namely, tracking healthcare treatment and device outcomes, compiling data on healthcare providers and standards of care; Providing an on-line referral database of health professionals, hospitals and treatment centersACTIVE—
036Health plan and employer financial risk management; surgical benefit management services; financial consulting, namely, providing predictive outcomes modeling for healthcare treatments and devicesACTIVE—
038Providing on-line chat rooms for transmission of messages among computer users concerning healthcare treatmentsACTIVE—
041Educational services, namely, providing courses of instruction via an interactive web site featuring educational information in the field of evaluating medical risks for medical procedures and distributing course materials in connection therewith; on-line journals, namely, blogs featuring educational information in the field of evaluating medical risks for medical procedures; Patient education tools, namely, on-line brochures for people considering health care treatmentsACTIVE—
042Computer services, namely, creating an on-line community for registered users to participate in discussions, get feedback from their peers, form virtual communities, and engage in social networking; hosting an on-line community web site featuring information concerning healthcare treatments; providing temporary use of online non-downloadable software applications for health care treatments; providing temporary use of online non-downloadable software for use in the education of patients in the field of medicine; providing temporary use of online non-downloadable software for tracking the outcomes of medical procedures; providing temporary use of online non-downloadable software to assist consumers in making informed health care decisions; providing temporary use of on-line non-downloadable software for health risk assessment and preventative health measuresACTIVE—
044Providing health care information; medical counseling, namely, providing decision support resources; providing medical information, consultancy and advisory services to patients on how to evaluate medical and health care treatment risks; providing an on-line database of information about medical diagnostics, medical devices, treatment options, medical reference guides, news and information concerning health care related topics; medical counseling, namely, providing consumers with decision-support services in the medical industryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 13, 2010MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 13, 2010ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 26, 2010ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 26, 2010REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 9, 2010NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 17, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 28, 2009NPUBNOTICE OF PUBLICATION—
Oct 9, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 9, 2009CNEAEXAMINERS AMENDMENT MAILED—
Oct 8, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 8, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Oct 8, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 27, 2009CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 27, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 4, 2009ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 8, 2009PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Apr 24, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 24, 2009ALIEASSIGNED TO LIE—
Apr 24, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 27, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 27, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 27, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 29, 2008CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 28, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 28, 2008DOCKASSIGNED TO EXAMINER—
Jun 30, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance